Physician profile
Neda Amiry
NPI 1215520960
$2,521.04
in general payments reported to CMS, 2019-2025
17 companies · $1,105 in 2025
The $1,105 reported for 2025 was more than what 86% of Gerontology (Nurse Practitioner) providers received nationally (typical 2025 total: $180).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $222 · 2023: $395 · 2024: $799 · 2025: $1,105.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,299.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,298.95 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abiomed | $375.64 | 2023-2025 | Impella |
| Boston Scientific Corporation | $285.03 | 2025 | Ams 700, Watchman Flx |
| Kyowa Kirin, INC. | $241.10 | 2024-2025 | |
| Acadia Pharmaceuticals INC | $219.61 | 2024-2025 | Daybue |
| Inspire Medical Systems, INC. | $149.92 | 2024 | Inspire |
| Janssen Pharmaceuticals, INC | $137.86 | 2024 | Spravato |
| Sumitomo Pharma America, INC. | $124.99 | 2023 | Gemtesa |
| Axsome Therapeutics, INC. | $124.36 | 2025 | Auvelity |
| Biohaven Pharmaceutical Holding Company Ltd. | $119.95 | 2022 | |
| Teva Pharmaceuticals USA, INC. | $114.14 | 2025 | Austedo Xr |
| Amarin Pharma, INC. | $112.66 | 2025 | Vascepa |
| Abbott Laboratories | $111.37 | 2023 | Freestyle Libre 3 |
| Lucid Diagnostics INC. | $102.14 | 2022 | |
| W. L. Gore & Associates, INC. | $91.98 | 2024 | Gore Viabahn Endoprosthesis With Heparin |
| Cvrx, INC. | $88.53 | 2025 | Barostim Neo System |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $81.40 | 2024 | |
| Coloplast Corp | $40.36 | 2023 | Altis |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Neda Amiry listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.